Editas Medicine to present EDIT-401 data at gene therapy congress Oct 6, 2025 09:00AM
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences Oct 6, 2025 09:00AM
Chardan Capital Markets Downgrades Editas Medicine (EDIT) to Neutral Dec 13, 2024 08:02AM
Chardan Capital Markets Reiterates Buy Rating on Editas Medicine (EDIT) Nov 5, 2024 04:19PM
Editas Medicine to Participate in Upcoming Investor Conferences Aug 28, 2024 09:00AM


Sep 30, 2021 08:00AM Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
Sep 30, 2021 08:00AM Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
Feb 10, 2021 09:40AM Editas Medicine (EDIT) PT Raised to $77 at Chardan Capital Markets
Oct 1, 2020 08:00AM Editas Medicine to Participate in Upcoming Investor Conference
Oct 1, 2020 08:00AM Editas Medicine to Participate in Upcoming Investor Conference
Oct 1, 2019 08:00AM Editas Medicine to Participate in Upcoming Investor Conferences
Oct 1, 2019 08:00AM Editas Medicine to Participate in Upcoming Investor Conferences
Apr 3, 2019 09:28AM Editas Medicine (EDIT) Buy Reiterated At Chardan After Strategic Collaboration Announcement
May 15, 2018 06:53AM Editas Medicine (EDIT) PT Lowered to $55 at Chardan Capital Markets
Oct 3, 2017 08:00AM Editas Medicine to Participate in Investor Conferences in October
Aug 9, 2017 04:03PM Editas Medicine Announces Second Quarter 2017 Results and Update
Mar 28, 2017 09:29AM Pre-Open Movers 03/28: (PSIX) (CARA) (SB) Higher; (CYRX) (ORIG) (MEET) Lower (more...)
Mar 27, 2017 05:56PM After-Hours Stock Movers 03/27: (PSIX) (OCN) (RHT) Higher; (CYRX) (EVH) (STOR) Lower (more...)
Mar 27, 2017 04:31PM Chardan Capital Markets Starts Editas Medicine (EDIT) at Buy